Home/Filings/4/0001437749-23-010511
4//SEC Filing

Lucchese Joseph 4

Accession 0001437749-23-010511

CIK 0001504167other

Filed

Apr 17, 8:00 PM ET

Accepted

Apr 18, 11:30 AM ET

Size

5.3 KB

Accession

0001437749-23-010511

Insider Transaction Report

Form 4
Period: 2023-04-15
Lucchese Joseph
Executive VP & CFO
Transactions
  • Award

    Stock Option (right to buy)

    2023-04-15+22,50522,505 total
    Exercise: $1.66Exp: 2032-04-14Common Stock (22,505 underlying)
Footnotes (1)
  • [F1]25% of the options vest on April 15, 2024, and the remaining shares will become exercisable in 36 equal monthly installments beginning on May 15, 2024, as long as the Reporting Person remains in continuous service with Timber Pharmaceuticals, Inc. through each vesting date.

Issuer

Timber Pharmaceuticals, Inc.

CIK 0001504167

Entity typeother

Related Parties

1
  • filerCIK 0001810134

Filing Metadata

Form type
4
Filed
Apr 17, 8:00 PM ET
Accepted
Apr 18, 11:30 AM ET
Size
5.3 KB